Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.
暂无分享，去创建一个
G. Hortobagyi | S. Singletary | F. Ames | K. Hunt | V. Valero | N. Ibrahim | D. Booser | R. Theriault | A. Buzdar | D. Frye | N. Ibrahim | E. Strom | K. Hunt | L. Asmar | T. Smith | M. Mcneese | S. Kau | T. Smith | N. Manuel | Nikki Manuel